| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |